Stay updated on BGB324 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BGB324 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The revision label updated from v3.5.4 to v3.5.5. This indicates a minor platform update rather than changes to the study content or data.
    Difference
    0.1%
    Check dated 2026-06-05T22:14:30.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Melanoma is added as a related topic on the page. A MedlinePlus Genetics cross-reference is now included to link users with genetics-related information about melanoma.
    Difference
    0.2%
    Check dated 2026-05-29T18:44:02.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The Melanoma keyword, the 'related topics' header, and the MedlinePlus Genetics link are removed from the page's related resources area, reducing cross-links to topic resources.
    Difference
    0.2%
    Check dated 2026-05-22T11:40:20.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Melanoma and related topics: MedlinePlus Genetics were added to the page's topic metadata, and the revision note updated from v3.5.3 to v3.5.4. This update serves as metadata/versioning information rather than a change to core content.
    Difference
    0.2%
    Check dated 2026-05-15T05:43:34.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Melanoma and MedlinePlus Genetics were added under Related topics, expanding the page with additional disease context and genetics resources for users.
    Difference
    0.2%
    Check dated 2026-05-08T10:27:36.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now reflects an updated ClinicalTrials.gov interface revision (v3.5.3) and the related generic topic/link section text was refreshed (with “Melanoma”/“related topics” and a prior revision reference removed). This represents a platform/content wrapper update rather than a change to the study record itself.
    Difference
    0.2%
    Check dated 2026-04-24T06:01:47.000Z thumbnail image

Stay in the know with updates to BGB324 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.